Filter by: patients
Home > Community Treatment Reports and Side Effects > SB-509 Treatment Report
What is SB-509?

The purpose of the study is to evaluate the effects of the investigational drug, SB-509 on progression of the disease in subjects with Amyotrophic Lateral Sclerosis (ALS). Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Participate in clinical trial 1 1 Efficacy_none

See 1 patient currently using SB-509

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Schedules

  60 mg one time
  1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Using SB-509 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 1   Course of treatment ended: 100%

See all 1 patient who’ve stopped using SB-509

Reported Duration See details about how long patients take this treatment ▼

Currently Using SB-509

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Using SB-509

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of SB-509

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of SB-509

Very
 0 0%
Somewhat
 1 100%
A little
 0 0%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of SB-509

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

Report created on February 11, 2012.